Chem Basis PPIs 6

Card Set Information

Chem Basis PPIs 6
2013-12-08 16:45:26
Chem Basis PPIs
Chem Basis PPIs 6
Show Answers:

  1. How many subunits does the H+, K+ - ATPase have and what are they?
    2, catalytic alpha (larger) and glycosylated regulatory beta
  2. Which residue is responsible for H+, K+ ATPase loss of the enzyme bound H+ into the extracytoplasmic space?
  3. Is the potassium binding region of H+, K+ - ATPase affected by LYS791?
  4. Extracystolic K+ binds to what residues on the H+, K+ - ATPase before being transferred into the parietal cell? GLU795 and GLU820
  5. Dephosphorylation of the H+, K+ - ATPase occurs at what point in its operation?
    Right before K+ release in the cytoplasm
  6. Phosphorylation of the H+, K+ - ATPase occurs at what point in its operations?
    Right before the H+ is expelled into the cytoplasm
  7. H+, K+ - ATPase has how many transmembrane segments?
  8. The H+, K+ - ATPase has how many CYS residues?
  9. What H+, K+ - ATPase residue is most critical to binding PPIs?
  10. Which residue of H+, K+ - ATPase is the inner CYS?
  11. What type of PPIs can interact with CYS882 (inner)?
    Those that are activated more slowly
  12. What type of bonding interaction do PPIs have with the H+, K+ - ATPase?
    Irreversible Covalent Disulfide (between sulfurs on CYS and PPI)
  13. (True/False) PPIs have very potent long lasting effects.
  14. Are the disulfide bonds formed between the H+, K+ -ATPase and the PPI readily reversible?
  15. What is capable of regenerating the PPI inhibited pump?
  16. What limits GSH reactivation of the PPI inhibited pump?
    Limited stores and PPIs that bind CYS822 (as CYS822 is deep and hidden from GSH)
  17. What races are the Poor CYP2C19-metabolizing phenotypes are
    prevalent in?
    • Chinese (14.3%),
    • Korean (14.0%)
    • Japanese (21.3%)
    • 3-5% of Caucasians and African Americans
  18. The greatest risk of PPI toxicity due to CYP2C19 inhibition occurs with what drugs?
    omeprazole and esomeprazole
  19. What PPI would you use in a CYP2C19 poor metabolizer to prevent toxic effects?
  20. Doses of PPIs should be decreased in what groups?
    Severe Hepatic impairment and febrile elderly
  21. What is achlorhydria?
    Lack of gastric acid
  22. Some PPIs have DDIs that cause decreased absorption of the other drugs, what are these drugs?
    • cephalosporin antibiotics (decreased
    • absorption)
    • ketoconazole (decreased tablet dissolution,leading to decreased absorption)
    • indinavir (decreased tablet dissolution,leading to decreased absorption)
  23. Some PPIs have DDIs that cause increased absorption of the other drugs, what are these drugs?
    • clarithromycin (increased absorption)
    • digoxin (increased absorption)
    • salicylates (increased enteric-coated tabletdissolution, leading to an increase in gastric side effects)
    • theophylline (increased absorption fromsustained release formulations)
    • vitamin B12 (decreased absorption)